Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield.
PSMA-11
clinical routine
gallium-68
molar activity
net precursor content
radiochemical yield
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
11 Mar 2022
11 Mar 2022
Historique:
received:
07
02
2022
revised:
28
02
2022
accepted:
07
03
2022
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
27
3
2022
Statut:
epublish
Résumé
[
Identifiants
pubmed: 35337140
pii: ph15030343
doi: 10.3390/ph15030343
pmc: PMC8953397
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Labelled Comp Radiopharm. 2020 Apr;63(4):162-173
pubmed: 31845408
Chem Rev. 2010 May 12;110(5):2858-902
pubmed: 20415480
Bioconjug Chem. 2012 Apr 18;23(4):688-97
pubmed: 22369515
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1878-86
pubmed: 18509635
Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96
pubmed: 24983957
Dalton Trans. 2019 Mar 26;48(13):4299-4313
pubmed: 30860215
Theranostics. 2013 Dec 10;4(1):47-80
pubmed: 24396515
EJNMMI Radiopharm Chem. 2017;1(1):6
pubmed: 29564383
EJNMMI Radiopharm Chem. 2021 Mar 24;6(1):14
pubmed: 33761040
EJNMMI Radiopharm Chem. 2021 Oct 9;6(1):34
pubmed: 34628570